Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Calabadions: New Broad-Spectrum Agents to Reverse Neuromuscular Blockade

Buscar en contenido

Contenido:

domingo, 3 de julio de 2016

Does EPO improve OOHCA outcomes

Screenshot 2016-07-03 10.51.40
St.Emlyn’s - By Simon Carley July 3, 2016
"...It’s another disappointing study for those of us interested in cerebral protection post OOHCA. Here at St.Emlyn’s we think it’s important to report negative trials as well as positive ones. This is a reasonably well designed study that again tells us that there is no magic bullet on the market for neuroprotection, but we must remember that we are not helpless. There are many aspects of care that we can deliver to improve post OOHCA care. The absence of a magic medicine just means that we need to continue to do the basics (and the not so basics) as well as we can. So don’t be disheartened. Keep doing the very best you can for your OOHCA patients.
Have a listen to Scott Wengart’s talk from SMACC Chicago on Intra-arrest care. You might not believe in everything he says, but feel the need to constantly improve, look for small gains and forever doing the best you can."